Monday

25th Sep 2023

Stakeholder

I love the EU - but the vaccine strategy is a fiasco

  • I love the EU, no doubt about that - but that doesn't mean that we have to close our eyes when things go wrong (Photo: European Parliament)

They say love makes blind. But in politics that is not and shóuld not be the case.

I love the EU, no doubt about that. I think that in these troubled times, European integration is the only sensible way forward for our continent.

Read and decide

Join EUobserver today

Become an expert on Europe

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

But that doesn't mean that we have to close our eyes when things go wrong. It's our duty to be the most vocal critic, especially when Europe falls short of its potential, and of our expectations.

And that's exactly what is happening right now, with the EU vaccine strategy… a fiasco.

The inconvenient truth behind the vaccine fiasco in the EU

After nearly two months, the roll out of vaccines is dramatically low in Europe.

On average, not more than four percent of European citizens received a first dose. And in most countries, vaccination nearly came to a halt.

In my own region, Flanders, centres are finally ready… and closed again, because vaccine deliveries are insufficient.

This is in stark contrast with our production capacity of vaccines.

Europe is the world leader in vaccine production. More than 75 percent of all vaccines are produced in Europe, as are the majority of the nearly 200 million Covid vaccines that have already been produced.

Nevertheless, there is a crucial lack of supply in every European member state. Meanwhile in the United States, nearly 10 percent of the population received a first dose. In Britain it's 20 percent.

So what is going wrong?

The president of the European Commission, Ursula von der Leyen, is basically saying 'we did nothing wrong, but were only a little bit too optimistic about our capacity to produce in Europe'.

But that's not what the facts are telling us, as we produce the vast majority of these vaccines… just to export them to other countries.

Weak contracts

How did this happen? Well, in my opinion, the answer lies in the contracts Europe negotiated with the pharmaceutical companies.

These contracts are extremely unbalanced. They are precise on pricing and liabilities but weak and vague on supply and on timing, and offer escape routes to the contractual obligations of the pharmaceutical companies involved.

The effect of these provisions is really devastating.

Only the amount of doses that, based on the contractual obligations of the companies is nót subject to be exported to countries like the UK, US, Israel, Canada or others, is today available for the vaccination of EU citizens, thereby prolonging the covid pandemic on the European continent.

And the measures meanwhile taken by the European Commission are mostly symbolic, insufficient and to some extent even counterproductive.

The use, for example, of Article 16 of the Northern Ireland protocol has been a diplomatic disaster, destroyed in a few seconds the seriousness of the negotiations with the UK, conducted by Michel Barnier for more than three years.

The introduction of a new export authorisation for Covid vaccines is only an unnecessary burden to the process and certainly doesn't speed up the vaccination of our European citizens.

The appointment of commissioner for industry Thierry Breton to further extend the vaccine production capacity in Europe is certainly a sensible move.

Yet it is not so much the capacity in Europe that constitutes the problem, but the allocation of the produced doses.

Ultimately, what is needed is a radical change in our strategy. In the short term, we need to use the power of the European Union to renegotiate the ill-conceived contracts with the pharmaceutical industry.

Binding commitments and mandatory timelines and volumes must replace the indicative goals that are foreseen today. Export clauses, as apparently the UK has in its contracts, respecting these commitments and timelines, need to be introduced.

And for the upcoming authorisations of vaccines from, for example, Johnson&Johnson and CureVac, that the European Medicines Agency must follow a fast-track procedure, putting aside the question of liabilities towards third parties.

And in the longer term, a real health union must be established with a real budget so that we can match the US in supporting the development and production of new medicines and treatments by the pharmaceutical industry.

Part of this union must also be a dedicated agency responsible for the European-wide acquisition of medicines to avoid the errors made during this pandemic. And finally, also, the question of patent rights needs to be openly discussed and addressed.

Because we cannot do without the European Union in this, as some might conclude from this fiasco.

As often, the European Union is not the problem, but the solid basis for the solution.

Author bio

Guy Verfhofstadt is an MEP with the liberal Renew Europe group, and a former prime minister of Belgium.

Disclaimer

This article is sponsored by a third party. All opinions in this article reflect the views of the author and not of EUobserver.

Von der Leyen concedes mistakes in vaccine rollout

The European Commission admitted mistakes were made during the bloc's approval and rollout of vaccines - triggering criticism from MEPs who demanded more transparency and accountability, plus solidarity with low and medium-income countries.

Safety fears suspend work for EU staff at Northern Irish ports

The issue will be discussed on Wednesday at a video conference between EU Commission vice president Maroš Šefcovic, British cabinet minister Michael Gove, Northern Ireland's first minister Arlene Foster, and deputy first minister Michelle O'Neill.

Analysis

The EU's vaccine strategy - the key points

As the EU Commission gets entangled in a dispute with one of the vaccine producers and gets heat for the perceived slow roll-out of the vaccines, we take a look at what the EU has done and not done.

Analysis

Hungary breaks with EU on Russia, China vaccines

While all governments are seeking to secure vaccines as fast as they can so they can open up their economies, so far only Hungary's Viktor Orban has chosen to break with the EU's vaccine strategy.

Worries on Europe's infection surge, after six-week drop

The World Health Organization warned of a surge in new coronavirus infections across Europe, pointing out healthcare systems should not be under pressure in some countries. Meanwhile, the European Medical Agency is reviewing Russia's Sputnik vaccine.

EU defends all vaccines, amid lower AstraZeneca take-up

The European Commission said that bloc's strict regulatory process for the evaluation and approval of vaccines is crucial to persuade citizens to get the jab, calling on member states to fight vaccine hesitancy with information.

US senators, MEPs call to keep fossil-fuel lobbyists out of COP28

We, the undersigned members of the US Congress and the European Parliament, address this letter to the president of the United States, the president of the European Commission, the secretary-general of the UN, and the executive secretary of the UNFCCC.

Latest News

  1. Europe's energy strategy: A tale of competing priorities
  2. Why Greek state workers are protesting new labour law
  3. Gloves off, as Polish ruling party fights for power
  4. Here's the headline of every op-ed imploring something to stop
  5. Report: Tax richest 0.5%, raise €213bn for EU coffers
  6. EU aid for Africa risks violating spending rules, Oxfam says
  7. Activists push €40bn fossil subsidies into Dutch-election spotlight
  8. Europe must Trump-proof its Ukraine arms supplies

Stakeholders' Highlights

  1. International Medical Devices Regulators Forum (IMDRF)Join regulators, industry & healthcare experts at the 24th IMDRF session, September 25-26, Berlin. Register by 20 Sept to join in person or online.
  2. UNOPSUNOPS begins works under EU-funded project to repair schools in Ukraine
  3. Georgia Ministry of Foreign AffairsGeorgia effectively prevents sanctions evasion against Russia – confirm EU, UK, USA
  4. International Medical Devices Regulators Forum (IMDRF)Join regulators & industry experts at the 24th IMDRF session- Berlin September 25-26. Register early for discounted hotel rates
  5. Nordic Council of MinistersGlobal interest in the new Nordic Nutrition Recommendations – here are the speakers for the launch
  6. Nordic Council of Ministers20 June: Launch of the new Nordic Nutrition Recommendations

Stakeholders' Highlights

  1. International Sustainable Finance CentreJoin CEE Sustainable Finance Summit, 15 – 19 May 2023, high-level event for finance & business
  2. ICLEISeven actionable measures to make food procurement in Europe more sustainable
  3. World BankWorld Bank Report Highlights Role of Human Development for a Successful Green Transition in Europe
  4. Nordic Council of MinistersNordic summit to step up the fight against food loss and waste
  5. Nordic Council of MinistersThink-tank: Strengthen co-operation around tech giants’ influence in the Nordics
  6. EFBWWEFBWW calls for the EC to stop exploitation in subcontracting chains

Join EUobserver

Support quality EU news

Join us